Additional file 1: Table S1. of The gene–treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry
- Akiko Sumi (443807)
- Udai Nakamura (483471)
- Masanori Iwase (483464)
- Hiroki Fujii (483463)
- Toshiaki Ohkuma (483462)
- Hitoshi Ide (483466)
- Tamaki Jodai-Kitamura (4681504)
- Yuji Komorita (4681501)
- Masahito Yoshinari (4681498)
- Yoichiro Hirakawa (483470)
- Atsushi Hirano (822713)
- Michiaki Kubo (128298)
- Takanari Kitazono (483472)
Publication date
December 2017
DOIAbstract
Clinical characteristics according to statin therapy. Data are expressed as mean ± SD, median (interquartile), and n (percentage). CVD: cardiovascular disease, OHA: oral hypoglycemic agents, α-GI: alpha-glucosidase inhibitor, DPP4-I: inhibitors of type 4 dipeptidyl peptidase.* log-transformed for the statistical analysis. (DOCX 15 kb
Add to ORKG